Abrdn PLC Ab Cellera Biologics Inc. Transaction History

Abrdn PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 20, 2024	SELL	$7.31 - $11.18 $41,922 - $64,117	-5,735 Reduced 2.02%	278,528 $2.1 Million
Q1 2023 Apr 28, 2023	SELL	$7.31 - $11.18 $41,922 - $64,117	-5,735 Reduced 2.02%	278,528 $2.1 Million
Q4 2022 Jun 20, 2024	BUY	$9.48 - $14.52 $2.69 Million - $4.13 Million	284,263 New	284,263 $2.88 Million
Q4 2022 Feb 09, 2023	BUY	$9.48 - $14.52 $83,717 - $128,226	8,831 Added 3.21%	284,263 $2.88 Million
Q3 2022 Nov 10, 2022	SELL	$9.2 - $13.68 $916,595 - $1.36 Million	-99,630 Reduced 26.56%	275,432 $2.72 Million
Q2 2022 Aug 05, 2022	SELL	$5.72 - $10.65 $202,430 - $376,903	-35,390 Reduced 8.62%	375,062 $3.92 Million
Q1 2022 May 04, 2022	SELL	$7.46 - $14.14 $446,301 - $845,939	-59,826 Reduced 12.72%	410,452 $4 Million
Q4 2021 Feb 08, 2022	BUY	$12.99 - $17.73 $576,756 - $787,212	44,400 Added 10.43%	470,278 $6.73 Million
Q3 2021 Nov 15, 2021	BUY	$14.85 - $21.34 $1.86 Million - $2.68 Million	125,450 Added 41.76%	425,878 $8.45 Million
Q2 2021 Aug 10, 2021	BUY	$20.19 - $34.17 $2.43 Million - $4.11 Million	120,300 Added 66.79%	300,428 $6.61 Million
Q1 2021 May 06, 2021	BUY	$23.29 - $53.2 $4.2 Million - $9.58 Million	180,128 New	180,128 $6.19 Million

153

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $787M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

Stay updated on Abrdn PLC with notifications on news.